Minireviews
Copyright ©The Author(s) 2023.
World J Hepatol. Jun 27, 2023; 15(6): 775-785
Published online Jun 27, 2023. doi: 10.4254/wjh.v15.i6.775
Table 2 Criteria applied for tumor budding in previous studies
Ref.
Tumor
Tumor budding criteria
Kairaluoma et al[75]HCCEvaluation was performed according to median values; Negative: No buds were found; Positive: At least one bud was present
Wei et al[76]HCCAssociation between TB and clinicopathological parameters; Grade 1 (0-4), Grade 2 (5-9), Grade 3 (≥ 10); For survival analysis; Low grade (0-9), High grade (≥ 10)
Okubo et al[77]CCCNegative: < 5 budding focus; Positive: ≥ 5 budding focus
Ogino et al[78]EHCC-PH, EHCC-DCCut-off values of TB obtained by recursive partioning technique; For EHCC-PH; Low grade (0-4), Intermediate grade (5-11), High grade (≥ 12); For EHCC-DC; Low grade (0-4), High grade (≥ 5)
Tanaka et al[80]ICC, EHCC-PH, EHCC-DCLow grade (0-4), Intermediate grade (5-9), High grade (≥10)
Ito et al[81]EHCC-PHLow TB: < 5 budding focus; High TB: ≥ 5 budding focus
Agostini-Vulaj et al[83]ICC, EHCCGrade 1 (0-4), Grade 2 (5-9), Grade 3 (≥ 10)
Budau et al[84]ICCGrade 1 (0-4), Grade 2 (5-9), Grade 3 (≥ 10)
Kosaka et al[85]ICCLow grade (0-4), Intermediate grade (5-9), High grade (≥ 10)
Nakayama et al[82]EHCC-DCLow TB (0-4), High [TB Grade 2 (5-9) and 3 (≥ 10)]